Revised Korean Antiviral Guideline Reduces the Hepatitis B-related Hepatocellular Carcinoma Risk in Cirrhotic Patients.
David Sooik KimSoo-Young ParkBeom Kyung KimJun Yong ParkDo Young KimKwang-Hyub HanYu Rim LeeWon Young TakYoung Oh KweonInkyung JungMinkyung HanEun Wha KimSang Hoon AhnSeung-Up KimPublished in: Journal of Korean medical science (2021)
The prognosis of patients with CHB-related cirrhosis who initiated AVT improved after guideline implementation according to the revised KASL guideline.